Results 121 to 130 of about 316,204 (367)

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

open access: yesCirculation, 2014
Preamble 2072 1. Introduction 2074 2. Clinical Characteristics and Evaluation of AF 2076 3. Thromboembolic Risk and Treatment 2077 4. Rate Control: Recommendations 2079 5. Rhythm Control: Recommendations 2080 6.
C. January   +15 more
semanticscholar   +1 more source

Closure of a Late‐Onset Iatrogenic Left Ventricular Pseudoaneurysm Caused by Erosion of an Apical Muscular VSD Device

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We report the case of a 3‐year‐old asymptomatic girl (12 kg, 96 cm) who was diagnosed with a large iatrogenic left ventricular pseudoaneurysm (LVP) on follow‐up ultrasound, 14 months after apical muscular ventricular septal defect (VSD) closure with a 10 mm Amplatzer Muscular VSD occluder (Abbott, USA) due to device erosion.
Raymond N. Haddad   +3 more
wiley   +1 more source

The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children.

open access: yesPLoS ONE, 2013
Preformed anti-HLA antibodies (AHA) are known to be associated with delayed engraftment and reduced overall survival after adult hematopoietic stem cell transplantation. However, limited data is available in pediatric patients. In this study, we explored
Marc Ansari   +13 more
doaj   +1 more source

Prototyping a process-centered environment [PDF]

open access: yes, 1990
This paper describes an experimental system developed and used as a vehicle for prototyping the Arcadia-1 software development environment. Prototyping is viewed as a knowledge acquisition process and is used to reduce risks in software development by ...
Aha, Stephanie Leif   +3 more
core  

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary.

open access: yesCirculation, 2019
Patrick T. O’Gara, MD, MACC, FAHA, Chair Joshua A. Beckman, MD, MS, FAHA, Chair-Elect Glenn N. Levine, MD, FACC, FAHA, Immediate Past Chair [‖][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Kim K. Birtcher, PharmD, MS, AACC Joaquin E.
Donna K. Arnett   +17 more
semanticscholar   +1 more source

Dual Antiplatelet Therapy Prior to Percutaneous Coronary Intervention for Acute Coronary Syndrome: Prevalence and Outcomes in Contemporary Practice

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Dual antiplatelet therapy (DAPT) is standard following percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Preloading is the practice of administering both aspirin and a P2Y12 inhibitor before PCI. DAPT preloading is common practice, however clinical trial evidence demonstrating benefit is lacking.
Shi Hui Goh   +11 more
wiley   +1 more source

PCSK‐9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST‐Elevation Myocardial Infarction Patients With Chronic Kidney Disease

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary slow flow and no reflow significantly predict poor prognosis in acute myocardial infarction (AMI) patients, especially those with chronic kidney disease (CKD). Early identification of factors contributing to these conditions can mitigate ischemic events and improve outcomes.
Hao Xu   +5 more
wiley   +1 more source

Anglo-American Labor History at the AHA [PDF]

open access: bronze, 1975
Judith R. Walkowitz, Daniel J. Walkowitz
openalex   +1 more source

Home - About - Disclaimer - Privacy